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Background
This work investigates the association of CD4+ T-cell acti-
vation and memory maturation during primary HIV infec-
tion with viral control during the first year of infection.
We hypothesize that an early accumulation of central/
transitional memory CD4 cells associates with succeeding
viral control.
Methods
We examined a cohort of 15 subtype C HIV-infected sub-
jects identified during primary HIV-1 infection (PHI).
Polychromatic flow cytometry was used to simultane-
ously analyze activation and memory maturation profiles
in total and antigen-specific CD4+ T cells. Isolated PBMC
from each subject were stimulated for 6 h with Gag, CMV
(pp65) or Ad5 Hexon peptide pools and labeled with a
cocktail of monoclonal antibodies to CD3, CD4, CD8,
CD45RO, CD27, HLA-DR, CD38, Ki-67, IFNγ and IL-2.
Results
Our results show that HIV Gag-specific CD4+ T-cells are
characterized by high level of activation that is not
observed total memory or non-HIV specific cells. The fre-
quency of central/transitional memory
(CD27+CD45RO+) CD4+ T cells expressing CD38+HLA-
DR+Ki67+ was significantly higher on Gag-specific com-
pared to total memory CD4+ cells (p = 0.0392) at 3
months post infection. The frequency of these cells nega-
tively correlated with viral load (r = -0.65, p = 0.021) at 12
months. Conversely, activated Gag-specific effector mem-
ory (CD27-CD45RO+) CD4+ T-cells at 3 months posi-
tively correlated with viral load (r = 0.63, p = 0.028) at 12
months.
Conclusion
These data show that activated and less differentiated Gag-
specific memory CD4+ T-cells during PHI may play a key
role in control of vireamia during the first year of infec-
tion.
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